Viewing Study NCT05295992


Ignite Creation Date: 2025-12-24 @ 3:35 PM
Ignite Modification Date: 2026-01-01 @ 3:15 PM
Study NCT ID: NCT05295992
Status: RECRUITING
Last Update Posted: 2023-03-14
First Post: 2022-03-04
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Conventionally Fractionated Adaptive Radiation Therapy of Bladder Cancer an Individualized Approach
Sponsor: Varian, a Siemens Healthineers Company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module